Mental Health News

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN), a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market (“Nasdaq”) from the NYSE American LLC (“NYSE American”). The Company expects that its common shares will cease trading on the NYSE American at market close...

DUBLIN--(BUSINESS WIRE)--The "Sexual Wellness Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The sexual wellness market is evolving rapidly, shaped by shifting consumer expectations, technological innovation, and expanding product portfolios. Senior decision-makers can leverage these market changes to identify new opportunities for growth, adapt to regulatory landscapes, and make informed strategic investments. Market Snapshot: Sexual Wellness Ma...

WASHINGTON--(BUSINESS WIRE)--New national and state data released today by the Partnership to Fight Chronic Disease (PFCD) projects that chronic disease is on pace to cost the United States as much as $47 trillion between 2024 and 2039, including $2.2 trillion annually in medical costs and nearly $900 billion each year in lost productivity by 2039. The analysis, conducted by GlobalData, highlights a stark reality: 5% of people account for nearly 50% of total health care spending, driven largely...

Tel Aviv and Boston--(BUSINESS WIRE)--Syremis Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health, today announced its launch with a $165 million financing. The Series A, co-led by Dexcel Pharma and Third Rock Ventures, with participation from Bain Capital Life Sciences, GV (Google Ventures), QVT, and Pictet will support the advancement of Syremis’ pipeline through clinical proof of concept. Schizophreni...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Launches PPD CorEvitas Alzheimer’s Disease Registry to Advance Real-World Evidence in Neurodegenerative Care....

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, “Strengthening Belonging for Underserved Boys.” The report explores how loneliness has become a pressing public health issue among boys, particularly those from racially and ethnically diverse backgrounds, rural communities, LGBTQ+ identities, and boys with differing physical and mental abilities. According to a Gallup poll, 25%...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced that the PALISADE-3 Phase 3 study of intranasal fasedienol for the acute treatment of social anxiety disorder did not demonstrate a statistically significant improvement on the primary endpoint of change on the Subj...

SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, a biotechnology company developing restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, today announced that Kevin Finney, President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT in San Francisco. About Autobahn Therapeutics Autobahn Therapeutics is a biotechnology company developing a portfolio of neuropsychia...

MINNEAPOLIS--(BUSINESS WIRE)--LifeSpeak assembles advisory team of eight leaders from Harvard Medical School, Stanford, IBM Watson and major media innovators...

RIVERSIDE, Calif.--(BUSINESS WIRE)--Manifest MedEx (MX), California’s largest nonprofit health data network, announced a new initiative with California Mental Health Services Authority (CalMHSA) to support secure and appropriate data exchange between behavioral health providers and broader care teams across California. Through this collaboration, MX will provide CalMHSA with admit, discharge, and transfer (ADT) notifications for inpatient and emergency department encounters involving individual...